Health ❯ Healthcare

Vaccines

COVID-19 Vaccines COVID-19 Public Health mRNA Vaccines Vaccine Safety Covid-19 Vaccines Vaccine Development mRNA Technology Public Health Policy Vaccine Policy

Moderna’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

The findings set up an FDA decision due by August 5.

Trump’s Surgeon General Pick Scrutinized for Deleted Posts Criticizing Him and HHS

Stories older than 24h

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

WHO Prequalifies First Malaria Treatment for Newborns

Kennedy Ends Senate Hearings as Cassidy Presses Him on Vaccines and Health Cuts

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

Court Freeze of U.S. Vaccine Panel Puts New Shots, Coverage in Limbo

Hemmati Emerges as Front-Runner to Lead FDA’s Vaccine and Biologics Center

Fiocruz Flags Rising Influenza A and Severe Respiratory Cases Across Brazil

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Brazil Launches 2026 Flu Vaccination Drive Across Most Regions

Pfizer, Valneva Seek Approval for Lyme Vaccine After >70% Efficacy in Phase 3

India Cites Strong Rabies Vaccine Capacity, Says No Central Record of Year‑Wise Output

Pfizer–Valneva Lyme Vaccine Shows Over 70% Efficacy but Misses Primary Endpoint

Bundestag Covid Inquiry Grills Lauterbach and Wieler After AfD Witness Labels Vaccines a 'Human Experiment'

FDA Expands GSK’s Arexvy to High-Risk Adults 18–49, Completing Trio of RSV Vaccines for Younger At‑Risk Group

White House Tightens Control of HHS, Elevates Chris Klomp as Kennedy’s Deputy

FDA Advisers Back 2026–27 Flu Shot Overhaul to Target Dominant H3N2 Variant

Pakistan’s Essential Drug Shortage Deepens as Price Notifications Stall